Clinical trials
Recruiting Phase 3 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 6 |
| Merck Sharp & Dohme LLC | 3 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2 |
| Akeso | 1 |
| Gilead Sciences | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 1 |
| Jina Pharmaceuticals Inc. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 24 |
| Breast Neoplasms | 6 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.